Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | BTN3A1 | O00481 | 9/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GALR3 | O60755 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9013663 | 1.00 | ALDH1A1 (0.59) | ALDH1A1ALOX15PTPN1BTN3A1LMNA | |
| Alcohol SCHEMBL4909375 | 0.96 | ALDH1A1 (0.55) | ALDH1A1ALOX15PTPN1BTN3A1LMNA | |
| Formic Acid SCHEMBL9013905 | 0.94 | ALDH1A1 (0.53) | ALDH1A1ALOX15PTPN1BTN3A1LMNA | |
| SCHEMBL1073135 | 0.88 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1BTN3A1 | |
| SCHEMBL9270945 | 0.88 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1BTN3A1 | |
| SCHEMBL1073133 | 0.88 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1BTN3A1 | |
| SCHEMBL3083781 | 0.88 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1BTN3A1 | |
| SCHEMBL9270948 | 0.88 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1BTN3A1 | |
| SCHEMBL4909382 | 0.84 | BTN3A1 (0.44) | ALDH1A1ALOX15PTPN1BTN3A1 | |
| SCHEMBL23036813 | 0.82 | ALDH1A1 (0.66) | ALDH1A1ALOX15PTPN1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4021411-A | Production of high molecular weight α,β-unsaturated aldehydes | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1977-05-03 | — | — | US | claimed |
| US-12357668-B2 | Anticancer activity of Buddleja saligna compositions | UNIVERSITY OF PRETORIA (ZA) | 2025-07-15 | — | — | US | disclosed |
| US-20220088109-A1 | Anticancer Activity of Buddleja Saligna Compositions | UNIVERSITY OF PRETORIA (ZA) | 2022-03-24 | — | — | US | disclosed |
| EP-3914276-A1 | ANTICANCER ACTIVITY OF BUDDLEJA SALIGNA COMPOSITIONS | University Of Pretoria (ZA) | 2021-12-01 | — | — | EP | disclosed |
| WO-2020152577-A1 | ANTICANCER ACTIVITY OF BUDDLEJA SALIGNA COMPOSITIONS | UNIVERSITY OF PRETORIA (ZA) | 2020-07-30 | — | — | WO | disclosed |
| US-20080200733-A1 | Processes For The Preparation Of Purified Solanesol, Solanesyl Bromide & Solanesyl Acetone | NICHOLAS PIRAMAL INDIA LIMITED (IN) | 2008-08-21 | — | — | US | disclosed |
| US-7276622-B2 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-02 | — | — | US | disclosed |
| WO-2007004090-A2 | IMPROVED PROCESSES FOR THE PREPARATION OF PURIFIED SOLANESOL, SOLANESYL BROMIDE AND SOLANESYL ACETONE | NICHOLAS PIRAMAL INDIA LIMITED (IN) | 2007-01-11 | — | — | WO | disclosed |
| US-20060173221-A1 | Method for producing oxygen-containing compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-08-03 | — | — | US | disclosed |
| EP-1609777-A1 | METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2005-12-28 | — | — | EP | disclosed |
| US-5527952-A | Process for producing aldehyde derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-06-18 | — | — | US | disclosed |
| US-5424478-A | Process for producing vitamin A derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-06-13 | — | — | US | disclosed |
| EP-0075238-B1 | PROCESS FOR THE PREPARATION OF 3-ALKYL-3-ACYLOXY-4-HYDROXYBUTENES | BASF Aktiengesellschaft (DE) | 1984-11-28 | — | — | EP | disclosed |
| US-4466922-A | COPPER CARBOXYLATE | BASF AKTIENGESELLSCHAFT (DE) | 1984-08-21 | — | — | US | disclosed |
| EP-0075238-A2 | Process for the preparation of 3-alkyl-3-acyloxy-4-hydroxybutenes | BASF Aktiengesellschaft (DE) | 1983-03-30 | — | — | EP | disclosed |
| US-4021411-A | Production of high molecular weight α,β-unsaturated aldehydes | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1977-05-03 | — | — | US | disclosed |
| US-3965193-A | Production of high molecular weight α,β-unsaturated aldehydes | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1976-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173221-A1 | Method for producing oxygen-containing compound | GPX4, DUOX2, SCO2 | ALDH1A1 863/4885ALOX15 76/4885PTPN1 4882/4885 |
| US-20080200733-A1 | Processes For The Preparation Of Purified Solanesol, Solanesyl Bromide & Solanesyl Acetone | NDUFB10, SQOR, ACAA2 | ALDH1A1 936/4885ALOX15 918/4885PTPN1 4270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.